Rubric Capital Management (New York)’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.7M | Buy |
|
|||||
|
2025
Q1 | $28.5M | Buy |
|
|||||
|
2024
Q4 | $17.3M | Sell |
|
|||||
|
2024
Q3 | $16.8M | Hold |
|
|||||
|
2024
Q2 | $15M | Sell |
|
|||||
|
2024
Q1 | $19.2M | Sell |
|
|||||
|
2023
Q4 | $7.62M | Hold |
|
|||||
|
2023
Q3 | $12.4M | Hold |
|
|||||
|
2023
Q2 | $13.6M | Hold |
|
|||||
|
2023
Q1 | $10.5M | Hold |
|
|||||
|
2022
Q4 | $11M | Hold |
|
|||||
|
2022
Q3 | $8.75M | Buy |
|
|||||
|
2022
Q2 | $5M | Buy |
|